Short Interest in BioSyent Inc. (OTCMKTS:BIOYF) Grows By 225.0%

BioSyent Inc. (OTCMKTS:BIOYF) was the recipient of a significant increase in short interest in January. As of January 31st, there was short interest totalling 3,900 shares, an increase of 225.0% from the January 15th total of 1,200 shares. Based on an average daily trading volume, of 14,800 shares, the short-interest ratio is presently 0.3 days.

BioSyent Stock Performance

BIOYF traded up $0.02 during midday trading on Wednesday, reaching $7.81. The company’s stock had a trading volume of 391 shares, compared to its average volume of 5,103. The company has a fifty day simple moving average of $7.84 and a 200 day simple moving average of $7.85. BioSyent has a twelve month low of $5.93 and a twelve month high of $8.90.

BioSyent Cuts Dividend

The company also recently announced a dividend, which was paid on Monday, December 16th. Shareholders of record on Monday, December 2nd were issued a dividend of $0.0322 per share. This represents a yield of 1.6%. The ex-dividend date of this dividend was Friday, November 29th.

BioSyent Company Profile

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.